Skip to content

13F-HR filed by Venrock Adviser, LLC

Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 33 holding rows worth $2,679,121,858.

Accession
0001615982-26-000011
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 33 entries on the cover page, a total value of $2,679,121,858 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,679,121,858 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
APOGEE THERAPEUTICS INC COM03770N101Stock8,493,321$714,882,829dollars as filed
ERASCA INC COM29479A108Stock16,382,812$265,073,898dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock4,148,428$203,480,393dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW3,685,448$185,893,997dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM6,474,485$130,331,383dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM1,180,000$99,025,600dollars as filed
DAMORA THERAPEUTICS INC36322Q206COMMON STOCK3,603,595$93,333,111dollars as filed
OCULAR THERAPEUTIX INC67576A100COM10,346,926$87,638,463dollars as filed
COGENT BIOSCIENCES INC19240Q201COM2,000,000$76,980,000dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM3,882,709$75,945,788dollars as filed
SAVARA INC805111101COM13,740,375$75,022,448dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock1,726,331$67,672,175dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,319,765$54,731,423dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK3,041,719$54,264,267dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,602,034$47,820,715dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK9,982,124$46,915,983dollars as filed
JADE BIOSCIENCES INC008064206COM NEW3,220,364$45,246,114dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock2,173,913$39,413,043dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK2,133,576$39,193,791dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK6,434,990$38,288,191dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK4,843,380$33,709,925dollars as filed
ENGENE HOLDINGS INC29286M105COM4,771,414$32,493,329dollars as filed
TENAX THERAPEUTICS INC88032L605COM NEW1,675,262$26,787,439dollars as filed
Adlai Nortye00704R109SPONSORED ADS3,212,731$22,232,099dollars as filed
CENTURY THERAPEUTICS INC15673T100COM8,695,652$19,652,174dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,379,965$19,609,303dollars as filed
CYBIN INC23256X407COM NEW3,851,654$18,487,939dollars as filed
SURROZEN INC86889P208COMMON STOCK632,931$18,437,280dollars as filed
SEPTERNA INC COM81734D104Stock506,056$12,160,526dollars as filed
KORRO BIO INC500946108COMMON STOCK1,009,500$11,427,540dollars as filed
ALTO NEUROSCIENCE INC COM SHS02157Q109Stock500,000$11,240,000dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM1,609,569$10,365,624dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK330,525$1,365,068dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001615982-26-000011this filing2026-05-15acceptance time not in the bulk data set